The natural history of multiple sclerosis

Neurologic Clinics

Volumn 13, Issue 1, 1995, Pages 119-146

  Weinshenker, B G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTERFERON; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

CAUSE OF DEATH; CLINICAL FEATURE; CONVALESCENCE; DEMENTIA; DEMYELINATING DISEASE; DISABILITY; DISEASE COURSE; EMOTIONAL STRESS; ENCEPHALOMYELITIS; GENDER; GENETIC POLYMORPHISM; HUMAN; MENTAL FUNCTION; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; RESPIRATORY TRACT INFECTION; REVIEW; SURVIVAL; THERMAL EXPOSURE;

EID: 0028928973     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0733-8619(18)30064-1     Document Type: Review

References (119)

1. Altrocchi P.H. Acute transverse myelopathy Arch Neurol 9 1963 111 119
2. Amato M.P. Fratiglioni L. Groppi C. Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis Arch Neurol 45 1988 746 748
3. Arnason B.G.W. Histocompatibility testing in multiple sclerosis Davison A.N. Humphrey J.H. Liversedge A.L. et a.l. Multiple Sclerosis Research 1975 Elsevier Amsterdam 80 84
4. Beatty W.W. Goodkin D.E. Screening for cognitive impairment in multiple sclerosis: An -evaluation of the mini-menlalstate_examination Arch Neuro L 47 1990 297 301
5. Beck R.W. Cleary P.A. Trobe J.D. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis N Engl J Med 329 1993 1764 1769
6. Berger J.R. Sheremata J.A. Persistent neurological deficit precipitated by hot bath test in multiple sclerosis JAMA 249 1983 1751 1753
7. Bertrams J. Hober P.G. Kuwert E.K. HLA-A antigens in multiple sclerosis Lancet 1 1974 1287
8. Birk K. Ford C. Smeltzer S. The clinical course of multiple sclerosis during pregnancy and the puerperium Arch Neurol 47 1990 738 742
9. Bornstein M.B. Miller A. Slagle S. A pilot trial of COP-1 in exacerbating-remitting multiple sclerosis N Engl J Med 317 1987 408 414
10. Bornstein M.B. Miller A. Slagle S. A placebo-controlled, double blind, randomized, two-center, pilot trial of COP-1 in chronic progressive multiple sclerosis Neurology 41 1991 533 539
11. Bradley W.G. Whitty C.W.M. Acute optic neuritis: Prognosis for development of multiple sclerosis J Neurol Neurosurg Psychiatr 31 1968 10 18
12. British and Dutch Multiple Sclerosis Azathioprine Trial Group: Double-masked trial of azathioprine in multiple sclerosis Lancet 2 1988 179 183
13. British and Dutch Multiple Sclerosis Azathioprine Trial Group: Histocompatibility antigens in MS patients participating in a multicentre trial of azathioprine J Neurol Neurosurg Psychiatr 51 1988 412 415
14. Clark V.A. Detels R. Visscher B.R. Factors associated with a malignant or benign course of multiple sclerosis JAMA 248 1982 856 860
15. Confavreux C. Aimard G. Devie M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients Brain 103 1980 281 300
16. D'Hooghe M.B. Ebers G.C. A population-based study of seasonal onset of multiple sclerosis in London, Ontario (abstract) Neurology 39 suppl 1 1989 244
17. D'Hooghe M.B. Warshawski F. Ebers G.C. Neurogenic pulmonary edema: Brainstem localization of responsible lesions (abstract) Neurology 39 suppl 1 1989 244
18. Detels R. Clark V.A. Valdiviezo N.L. Factors associated with a rapid course of multiple sclerosis Arch Neurol 39 1982 337 341
19. Duquette P. Decary F. Pleines J. Clinical subgroups of MS in relation to HLA: DR alleles as possible markers of disease progression Can J Neurol Sei 12 1985 106 110
20. Ebers C. Optic neuritis and multiple sclerosis Arch Neurol 42 1985 702 704
21. Ellison G.W. Myers L.W. Mickey M.R. A placebo-controlled, randomized, double- masked, variable dosage, clinical trial of azathioprine with and without methylpred- nisolone in multiple sclerosis Neurology 39 1989 1018 1026
22. Engell T. Raun N.E. Thomsen M. HLA and heterogeneity of MS Neurology 32 1982 1043 1046
23. Fauchet R. Madigand M. Gueguen-Duchesne M.Y. Les marquers Bf et C4 du complement dans la SP Rev Neurol (Paris) 140 1984 422 425
24. Feinstein A. Ron M. Thompson A. A serial study of psychometric and magnetic resonance imaging changes in multiple sclerosis Brain 116 1993 569 602
25. Filippi M. Miller D.H. Paty D.W. Correlations between changes in disability and MPT activity in MS: A 2-year follow-up study 1993 Italy In Abstracts of the Ninth Congress of the European Committee for Treatment and Research in MS. Florence
26. Ford B. Tampieri D. Francis G. Long-term follow-up of acute partial transverse myelopathy Neurology 42 1992 250 252
27. Gay D. Dick G. Upton G. Multiple sclerosis associated with sinusitis: Case-controlled study in general practice Lancet 1 1986 815 819
28. Goodkin D.E. Hertsgaard D. Seasonal variation of multiple sclerosis exacerbations in North Dakota Arch Neurol 46 1989 1015 1018
29. Goodkin D.E. Hertsgaard D. Rudick R.A. Exacerbation rates and adherence to disease type in a prospectively folio wed-up population with multiple sclerosis Implications for clinical trials. Arch Neurol 46 1989 1107 1112
30. Goodkin D.E. Bailly R.C. Teetzen M.L. The efficacy of azathioprine in relapsing- remitting multiple sclerosis Neurology 41 1991 20 25
31. Goodkin D.E. Cookfair D. Wende K. Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS) Multiple Sclerosis Collaborative Research Group. Neurology 42 1992 859 863
32. Grant I. Brown G.W. Harris T. Severely threatening events and marked life difficulties preceding onset or exacerbations of multiple sclerosis J Neurol Neurosurg Psy- chiatr 52 1989 8 13
33. Hammond S.R. English D. de Wytt C. The clinical profile of MS in Australia: A comparison between medium- and high-frequency prevalence zones Neurology 38 1988 980 986
34. Huber S.J. Bornstein R.A. Rammohan K.W. Magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis J Neuropsychiatr Clin Neu- rosci 4 1992 152 158
35. Jacobs L. Salazar A.M. Herndon R. Multicentre double-blind study of effect of in- trathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis Lancet 2 1986 1411 1413
36. Jersild C. Fog T. Hansen G.S. Histocompatibility determinants in multiple sclerosis with special reference to clinical course Lancet 2 1973 1221 1225
37. Kesserling J. Miller D.H. Robb S.A. Acute disseminated encephalomyelitis: MRI findings and the distinction from multiple sclerosis Brain 113 1990 291 302
38. Kidd D. Revecz T.R. Thompson A.J. A comparative clinicopathological study of progressive multiple sclerosis (abstract) Ann Neurol 34 1993 308
39. Koopmans R.A. Li D.K.B. Grochowski E. Benign versus chronic progressive multiple sclerosis: Magnetic resonance imaging features Ann Neurol 25 1989 74 81
40. Krupp L.B. Alvarez L.A. LaRocca N.G. Fatigue in multiple sclerosis Arch Neurol 45 1988 435 437
41. Kurland L.T. Beebe G.W. Kurtzke J.F. Studies on the natural history of multiple sclerosis: 2. The progression of optic neuritis to multiple sclerosis Acta Neurol Scand 42 suppl 19 1966 157 176
42. Kurtzke J.F. The disability status scale for MS: Apologia pro DSS sua Neurology 39 1989 291 302
43. Kurtzke J.F. Beebe G.W. Nagler B. Studies on the natural history of multiple sclerosis 7. Correlates of clinical change in an early bout. Acta Neurol Scand 49 1973 379 395
44. Kurtzke J.F. Beebe G.W. Nagler B. Studies on the natural history of multiple sclerosis VIII Early prognostic features of the later course of the illness. J Chronic Dis 30 1977 819 830
45. Lee K.H. Hashimoto S.A. Hooge J.P. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis Neurology 41 1991 657 660
46. Lipton H.L. Teasdale R.D. Acute transverse myelopathy in adults: A follow-up study Arch Neurol 28 1973 252 257
47. Long D.D. Miller B.J. Suicidal tendency and multiple sclerosis Health and Social Work 16 1991 104 109
48. MacLean A.R. Berkson J. Woltman H.W. Multiple sclerosis in a rural community Res Publ Assoc Res Nerv Ment Dis 28 1950 25 27
49. Madigand M. Oger J.J.F. Fauchet R. HL A profiles in MS suggest two forms of the disease and the existence of protective haplotypes J Neurol Sei 53 1982 519 529
50. Malmgren R. Detels R. Visscher B. The effect of stress on the course of multiple sclerosis 1984 Vancouver, BC, Canada In Abstracts of the 10th Meeting of the International Epidemiological Association
51. Mandler R.N. Davis L.E. Jeffrey D.R. Devic's neuromyelitis optica: A clinicopathological study of eight patients Ann Neurol 34 1993 162 168
52. Mapelli G. Pavoni M. DePalma P. Progression of optic neuritis to multiple sclerosis: A prospective study in an Italian population Neuroepidemiology 10 1991 117 121
53. Matthews P.M. Francis G. Antel J. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis Neurology 41 1991 1251 1256
54. Matthews W.B. Clinical aspects Matthews W.B. Acheson E.D. Batchelor J.R. et a.l. Me Alpine's Multiple Sclerosis 1985 Churchill Livingstone Edinburgh 49 278
55. Maurelli M. Marchioni E. Cerretano R. Neuropsychological assessment in MS: Clinical, neurophysiological and neuroradiological relationships Acta Neurol Scand 86 1992 124 128
56. Maviani C. Farina E. Cappa S.F. Neuropsychological assessment in multiple sclero- sis: A follow-up study with magnetic resonance imaging J Neurol 238 1991 395 400
57. McAlpine D. The benign form of multiple sclerosis A study based on 241 cases seen within 3 years of onset and followed up until the 10th year or more of the disease. Brain 84 1961 186 203
58. Me Alpine D. The benign form of multiple sclerosis: Results of a long-term study Br Med J 2 1964 1029 1032
59. Meyer-Rienecker H.J. Wegener S. Hitzchke B. Multiple sclerosis: Relation between HLA haplotype A25, B18, and disease progression Acta Neurol Scand 676 1982 709 712
60. Minderhoud J.M. Van Der Hoeven J.H. Prange A.A. Course and prognosis of chronic progressive multiple sclerosis Results of an epidemiological study. Acta Neurol Scand 78 1988 10 15
61. Nisipeanu P. Korczyn A.D. Psychological stress as risk factor for exacerbations in multiple sclerosis Neurology 43 1993 1311 1312
62. Nose worthy J.H. Vandervoort M.K. Wong C.J. Interrater variability with the expanded disability status scale (EDSS) and functional systems (FS) in a multiple sclerosis clinical trial Neurology 40 1990 971 975
63. Oksenberg J.R. Begovich A.B. Erlich H.A. Genetic factors in multiple sclerosis JAMA 270 1993 2362 2369
64. Olerup O. Hillert J. Fredrikson S. Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two immunogenetically distinct disease entities Proc Natl Acad Sei 86 1989 7113 7117
65. Olerup O. Hillert J. HLA class ?-associated genetic susceptibility in multiple sclerosis: A critical evaluation Tissue Antigens 38 1991 1 15
66. Paty D. Willoughby E. Whitaker J. Assessing the outcome of experimental therapies in multiple sclerosis patients Rudick R.A. Goodkin D.E. Treatment of Multiple Sclerosis 1992 Springer Verlag London 47 90
67. Paty DW, Li DKB, UBC MS/MRI Study Group, et al: Interferon-ßlb is effective in relapsing remitting multiple sclerosis II: MRI analysis results. Neurology 43:662-667, 1993
68. Percy A.K. Nobrega F.T. Kurland L.T. Optic neuritis and multiple sclerosis: An epidemiologic study Arch Ophthalmol 87 1972 135 139
69. Phadke J.G. Survival pattern and cause of death in patients with multiple sclerosis: Results from an epidemiological survey in North East Scotland J Neurol Neurosurg Psy- chiatr 50 1987 523 531
70. Phadke J.G. Clinical aspects of multiple sclerosis in North East Scotland with particular reference to its course and prognosis Brain 113 1990 1597 1628
71. Poser C.M. Paty D.W. Scheinberg L. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols Ann Neurol 13 1983 227 231
72. Poser S. Ritter G. Bauer H.J. HLA-antigens and the prognosis of multiple sclerosis J Neurol 225 1981 219 221
73. Poser S. Kurtzke J.F. Poser W. Survival in multiple sclerosis J Clin Epidemiol 42 1989 159 168
74. Rao S.M. Leo G.J. Bernardin L. Cognitive dysfunction in multiple sclerosis I Frequency, patterns, and prediction. Neurology 41 1991 685 691
75. Rao S.M. Leo G.J. Ellington L. Cognitive dysfunction in multiple sclerosis II Impact on employment and social functioning. Neurology 41 1991 692 696
76. Rao S.M. Leo G.J. Haugton V.M. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis Neurology 39 1989 161 166
77. Raun N.G. Fog T. Heltberg A. Correlation of the course of MS and histocompatibility antigen Boule H.J. Poser S. Ritler G. Progress in MS Research 1980 Springer-Verlag Berlin 456 459
78. Reder A.T. Antel J.P. Clinical spectrum of multiple sclerosis Neurol Clin 1 1983 573 600
79. Riise T. Gronning M. Aarli J.A. Prognostic factors for life expectancy in multiple sclerosis analyzed by Cox models J Clin Epidemiol 41 1988 1031 1036
80. Riise T. Gronning M. Fernandez O. Early prognostic factors for disability in multiple sclerosis, a European multicenter study Acta Neurol Scand 85 1992 212 218
81. Rizzo J.F. Lesseil S. Risk ol developing multiple sclerosis after uncomplicated optic neuritis: A long-term prospective study Neurology 38 1988 185 190
82. Rodriguez M. Karnes W.E. Bartleson J.D. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination Neurology 43 1993 1100 1104
83. Rodriguez M. Siva A. Cross S. Optic neuritis: A population-based study in Olmsted County, Minnesota Neurology 44 1994 A374
84. Rodriguez M. Siva A. Ward J. Impairment, disability, and handicap in multiple sclerosis: A population-based study in Olmsted Country, Minnesota Neurology 44 1994 28 33
85. Ropper A.H. Poskanzer D.C. Prognosis of acute and subacute transverse myelopathy based on early signs and symptoms Ann Neurol 4 1978 51 59
86. Runmarker B. Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with 25 years of follow-up Brain 116 1993 117 134
87. Runmarker B. Andersson C. Oden A. Multivariate analysis of prognostic factors in multiple sclerosis J Neurol 241 1994 597 604
88. Sadovnick A.D. Ebers G.C. Wilson R.W. Life expectancy in patients attending multiple sclerosis clinics Neurology 42 1992 991 994
89. Sadovnick A.D. Eisen K. Ebers G.C. Cause of death in patients attending multiple sclerosis clinics Neurology 41 1991 1193 1196
90. Sadovnick A.D. Paty D.W. Hashimoto S.A. Multiple sclerosis and pregnancy: A prospective study (abstract) Neurology 40 suppl 1 1990 141
91. Sandberg-Wollheim M. Bynke H. Cronqvist S. A long-term prospective study of optic neuritis: Evaluation of risk factors Ann Neurol 27 1990 386 393
92. Sharief M.K. Hentges R. Association between tumor necrosis factor-a and disease progression in patients with multiple sclerosis N Engl J Med 325 1991 467 472
93. Sibley W.A. Foley J.M. Infection and immunization in multiple sclerosis Ann NY Acad Sei 122 1965 457 468
94. Sibley W.A. Bamford C.R. Clark K. Clinical viral infections and multiple sclerosis Lancet 1 1985 1313 1315
95. Sibley W.A. Bamford C.R. Clark K. A prospective study of physical trauma and multiple sclerosis J Neurol Neurosurg Psychiatr 54 1991 584 589
96. Stenager E.N. Stenager E. Koch-Henriksen N. Suicide and multiple sclerosis: An epidemiological investigation J Neurol Neurosurg Psychiatr 55 1992 542 545
97. Stendahl-Brodin L. Link H. Möller G. Genetic basis of MS: HLA antigens disease progression, and oligoclonal IgG in CSF Acta Neurol Scand 59 1979 297 308
98. Swirsky-Sacchetti T. Field H.L. Mitchell D.R. The sensitivity of the mini-mental state exam in the white matter dementia of multiple sclerosis J Clin Psychol 48 1992 779 786
99. The Canadian Cooperative Multiple Sclerosis Study Group: The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis Lancet 337 1991 441 446
100. The IFNB Multiple Sclerosis Study Group: Interferon-ßlb is effective in relapsing-re- mitting multiple sclerosis. I. Clinical results of a multicenter, randomized, doubleblind, placebo-controlled trial Neurology 43 1993 655 661
101. The Multiple Sclerosis Study Group: Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double-blinded, placebo-controlled clinical trial Ann Neurol 27 1990 591 605
102. Thompson A.J. Hutchinson M. Brazil J. A clinical and laboratory study of benign multiple sclerosis Q J Med 58 1986 69 80
103. Thompson A.J. Kermode A.G. Wicks D. Major differences in the dynamics of primary and secondary progressive multiple sclerosis Ann Neurol 29 1991 53 62
104. Trojano M. Avolio C. Manzari C. Predictive models of long-term clinical course in multiple sclerosis patients 1993 Italy In Abstracts of the Ninth Congress of the European Committee for Treatment and Research in MS. Florence
105. Warren S. The role of stress in multiple sclerosis Rao S.M. Neurobehavioral Aspects of Multiple Sclerosis 1990 Oxford University Press New York 196 209
106. Weiner H.L. Mackin G.A. Orav E.J. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: Final report of the Northeast Cooperative Multiple Sclerosis Treatment Group Neurology 43 1993 910 918
107. Weinshenker B.G. Ebers G.C. The natural history of multiple sclerosis Can J Neurol Sei 14 1987 255 261
108. Weinshenker B.G. Rodriguez M. Epidemiology of Multiple Sclerosis Gorelick P.B. Alter J. Handbook of Neuroepidemiology 1994 Marcel Dekker New York 533 564
109. Weinshenker B.G. Baskerville J. Ebers G.C. Identifying suitable candidates for clinical trails of progressive MS (abstract) Ann Neurol 34 1993 273
110. Weinshenker B.G. Bass B. Rice G.P.A. The natural history of multiple sclerosis: A geographically based study 1 Clinical course and disability. Brain 112 1989 133 146
111. Weinshenker B.G. Bass B. Rice G.P.A. The natural history of multiple sclerosis: A geographically based study 2 Predictive value of the early clinical course. Brain 112 1989 1419 1428
112. Weinshenker B.G. Bulman D. Carriere W. A comparison of sporadic and familial multiple sclerosis Neurology 40 1990 1354 1358
113. Weinshenker B.G. Hader W. Carriere W. The influence of pregnancy on disability from multiple sclerosis: A population-based study in Middlesex County, Ontario Neurology 39 1989 1438 1440
114. Weinshenker B.G. Rice G.P.A. Noseworthy J.H. The natural history of multiple sclerosis: A geographically based study 3 Multivariate analysis of predictive factors and models of outcome. Brain 114 1991 1045 1056
115. Weinshenker B.G. Rice G.P.A. Noseworthy J.H. The natural history of multiple sclerosis: A geographically based study 4 Applications to planning and interpretation of clinical therapeutic trails. Brain 114 1991 1057 1067
116. Wiebe S. Lee D.H. Karlik S.J. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis: Clinical correlations and implications for classification of disease course Ann Neurol 32 1992 643 650
117. Willoughby E.W. Paty D.W. Scales for rating impairment in multiple sclerosis: A critique Neurology 38 1988 1793 1798
118. Willoughby E.W. Grochowski E. Li D.K.B. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients Ann Neurol 25 1989 43 49
119. Wynn D.R. Rodriguez M. O'Fallon M. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota Neurology 40 1990 780 786